Nanno Y, Toyama H, Mizumoto T, Ishida J, et al. Preoperative level of serum transthyretin as a novel biomarker predicting survival in resected pancreatic ductal adenocarcinoma with neoadjuvant therapy. Pancreatology 2024 Jul 31:S1424-3903(24)00692-6. doi: 10.1016/j.pan.2024.
PMID: 39181757